Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. RGMP.PINK

Regnum Corp (RGMP PINK) stock market data APIs

$0.0001 0(0%) as of July 25, 2024
Price chart is built with Anychart

Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody C"C chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company was incorporated in 2016 and is based in New York, New York.

Regnum Corp Financial Data Overview

0.0001
0.0001
-
0.0001
0.0001
0.0001-0.499
2 295
22 950 K
2 250
2.81
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'RGMP',
Type: 'Common Stock',
Name: 'Regnum Corp',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00JQ51VL5',
ISIN: NULL,
CUSIP: NULL,
CIK: '1716324',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Regnum Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 2 250
  • EBITDA -363 566
  • Earnings Per Share -0.03
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Regnum Corp Earnings via APIs

  • Latest Release 2024-07-22
  • EPS/Forecast NaN

Get Regnum Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Regnum Corp latest news via APIs

Regnum Signs Assignment and Assumption Agreement with CytoDyn and SevenScore Pharmaceuticals to Commercialize Leronlimab in the U.S. for the Treatment of HIV

In exchange for the exclusive right to market and distribute leronlimab in the U.S. for HIV-related indications, SevenScore will receive 4,094,023 shares of Regnum Corp. NEW YORK, Jan. 10, 2022 /PRNe...
  • CLINICAL TRIALS
  • CYTODYN
  • CYTODYN INC
  • FDA APPROVAL
  • HIV INFECTION
  • HIV-INFECTED PATIENTS
  • REGNUM
  • SEVENSCORE
  • TREATMENT OPTIONS
Do you have any questions?
support@eodhistoricaldata.com